Dr. Falk Pharma’s norucholic acid (NCA) drug has demonstrated potential in a Phase III trial for primary sclerosing ...

A major financial institution has unveiled a “bold” new mortgage product with a significant difference – borrowers won’t actually pay anything off their home.